Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of January 2026
Joseph Corr @Joseph Corr
Platinum member since January 2017

Location: United States

Gender: Male

Asset investment style: Qualitative fundamental analysis

Market capitalization:

$7,982,610talents

Virtual portfolio value:

$5,041,410talents

Net overall return per annum:

19.59%

AYA current rank order:

#17

Asset investment philosophy:
Joseph Corr trades U.S. stocks with the top #301 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 110,866 +793.33% $131,931
VATE INNOVATE Corp. Common Stock $0.53 $4.14 31,377 +681.13% $113,271
XBIOW Xenetic Biosciences Inc. Warrants $2.00 $23.16 4,407 +1,058.00% $93,252
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 9,200 +2,108.33% $69,828
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,387 +589.24% $56,964
HZNP Horizon Therapeutics Public Limited Company Ordinary Shares $16.41 $98.56 589 +500.61% $48,386
TUEM Tuesday Morning Corp. Common Stock $0.12 $0.69 74,858 +475.00% $42,669
NTZ Natuzzi S.p.A. $2.21 $11.92 4,376 +439.37% $42,491
MRNS Marinus Pharmaceuticals Inc. Common Stock $1.94 $11.62 2,308 +498.97% $22,341
BBX BBX Capital Corporation $2.54 $14.54 1,545 +472.44% $18,540
Sum $639,673

Blog+More

Government intervention remains a major influence over global trade, finance, and technology.

Amy Hamilton

2023-08-31 10:22:00 Thursday ET

Government intervention remains a major influence over global trade, finance, and technology.

Government intervention remains a major influence over global trade, finance, and technology. Nowadays, many governments tend to eschew common ownership

+See More

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fundamental analysis of Netflix (U.S. stock symbol: $NFLX).

Daisy Harvey

2025-10-03 10:31:00 Friday ET

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fundamental analysis of Netflix (U.S. stock symbol: $NFLX).

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund

+See More

American unemployment declines to the 50-year historical low level of 3.5% with moderate job growth.

Chanel Holden

2019-11-19 09:33:00 Tuesday ET

American unemployment declines to the 50-year historical low level of 3.5% with moderate job growth.

American unemployment declines to the 50-year historical low level of 3.5% with moderate job growth. Despite a sharp slowdown in U.S. services and utilities

+See More

Treasury Secretary Steve Mnuchin has released a 147-page report on U.S. financial deregulation.

Peter Prince

2017-05-25 08:35:00 Thursday ET

Treasury Secretary Steve Mnuchin has released a 147-page report on U.S. financial deregulation.

Treasury Secretary Steve Mnuchin has released a 147-page report on financial deregulation under the Trump administration. This financial deregulation seeks

+See More

Carmen Reinhart and Kenneth Rogoff analyze long-run crisis data to find the root causes of financial crises for better bank capital regulation and asset market stabilization.

Laura Hermes

2023-06-28 09:29:00 Wednesday ET

Carmen Reinhart and Kenneth Rogoff analyze long-run crisis data to find the root causes of financial crises for better bank capital regulation and asset market stabilization.

Carmen Reinhart and Kenneth Rogoff delve into several centuries of cross-country crisis data to find the key root causes of financial crises for asset marke

+See More

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More